BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Vasudevan A, Gibson PR, Langenberg DRV. Time to clinical response and remission for therapeutics in inflammatory bowel diseases: What should the clinician expect, what should patients be told? World J Gastroenterol 2017; 23(35): 6385-6402 [PMID: 29085188 DOI: 10.3748/wjg.v23.i35.6385]
URL: https://www.wjgnet.com/1007-9327/full/v23/i35/6385.htm
Number Citing Articles
1
Shintaro Sagami, Taku Kobayashi, Kanako Aihara, Misaki Umeda, Kazuhiro Odajima, Hiromu Morikubo, Kunio Asonuma, Yusuke Miyatani, Tomohiro Fukuda, Mao Matsubayashi, Hiroki Kiyohara, Masaru Nakano, Toshifumi Hibi. Early improvement in bowel wall thickness on transperineal ultrasonography predicts treatment success in active ulcerative colitisAlimentary Pharmacology & Therapeutics 2022; 55(10): 1320 doi: 10.1111/apt.16817
2
Xue-Liang Sun, Shi-Yi Chen, Shan-Shan Tao, Li-Chao Qiao, Hong-Jin Chen, Bo-Lin Yang. Optimized timing of using infliximab in perianal fistulizing Crohn's diseaseWorld Journal of Gastroenterology 2020; 26(14): 1554-1563 doi: 10.3748/wjg.v26.i14.1554
3
Jurij Hanžel, Rocio Sedano, Jenny Jeyarajah, Guangyong Zou, Stefanie C McFarlane, Christopher Ma, Vipul Jairath. Similar Clinical Improvement Rates Among Biologic Drug Classes in Crohn’s Disease: Systematic Review and Meta-RegressionInflammatory Bowel Diseases 2022;  doi: 10.1093/ibd/izac018
4
Rebecca L. Smith, Kirstin M. Taylor, Antony B. Friedman, David J. Gibson, Danny Con, Peter R. Gibson. Early sonographic response to a new medical therapy is associated with future treatment response or failure in patients with inflammatory bowel diseaseEuropean Journal of Gastroenterology & Hepatology 2022; 34(6): 613 doi: 10.1097/MEG.0000000000002367
5
Yan Xu, Aditi Sharma, Yang Chen, Honghui Zhou. What We Can Learn from Current Inflammatory Bowel Disease (IBD) Biological Therapy—Dose Regimen and OthersCurrent Pharmacology Reports 2019; 5(3): 115 doi: 10.1007/s40495-019-00180-x
6
Zhe Han, Liying Shi. Long non-coding RNA LUCAT1 modulates methotrexate resistance in osteosarcoma via miR-200c/ABCB1 axisBiochemical and Biophysical Research Communications 2018; 495(1): 947 doi: 10.1016/j.bbrc.2017.11.121
7
Arthur Geraud, Paul Gougis, Aurore Vozy, Celine Anquetil, Yves Allenbach, Emanuela Romano, Elisa Funck-Brentano, Javid J. Moslehi, Douglas B. Johnson, Joe-Elie Salem. Clinical Pharmacology and Interplay of Immune Checkpoint Agents: A Yin-Yang BalanceAnnual Review of Pharmacology and Toxicology 2021; 61(1): 85 doi: 10.1146/annurev-pharmtox-022820-093805
8
Hee-Sook Lim, Soon-Kyung Kim, Su-Jin Hong. Food Elimination Diet and Nutritional Deficiency in Patients with Inflammatory Bowel DiseaseClinical Nutrition Research 2018; 7(1): 48 doi: 10.7762/cnr.2018.7.1.48
9
Alessandro Armuzzi, Luisa Avedano, Kay Greveson, Taegyun Kang. Nurses are Critical in Aiding Patients Transitioning to Biosimilars in Inflammatory Bowel Disease: Education and Communication StrategiesJournal of Crohn's and Colitis 2019; 13(2): 259 doi: 10.1093/ecco-jcc/jjy150
10
Dario Sorrentino, Vu Q. Nguyen, Kim Love. Fecal Lactoferrin Predicts Primary Nonresponse to Biologic Agents in Inflammatory Bowel DiseaseDigestive Diseases 2021; 39(6): 626 doi: 10.1159/000515432
11
Rafael Martín-Masot, Pilar Ortiz Pérez, Encarnación Torcuato Rubio, Javier Blasco Alonso, Marta Herrador López, Carmen Gallego Fernández, Víctor Manuel Navas-López. The New Molecules Are Changing the Course of Pediatric Chronically Active Ulcerative Colitis: A Series of Pediatric CasesJPGN Reports 2021; 2(3): e100 doi: 10.1097/PG9.0000000000000100
12
Zahra Ghafouri, Saeid Seyyedian, Jafar Nikbakht, Ebrahim Kouhsari, Sara Bayat, Hamidreza Zargar, Gholamreza Houshmand. Effect of Sodium Cromoglycate on Acetic Acid-induced Ulcerative Colitis in MiceThe Korean Journal of Gastroenterology 2020; 75(1): 39 doi: 10.4166/kjg.2020.75.1.39
13
Arshdeep Singh, Ramit Mahajan, Saurabh Kedia, Amit Kumar Dutta, Abhinav Anand, Charles N. Bernstein, Devendra Desai, C. Ganesh Pai, Govind Makharia, Harsh Vardhan Tevethia, Joyce WY Mak, Kirandeep Kaur, Kiran Peddi, Mukesh Kumar Ranjan, Perttu Arkkila, Rakesh Kochhar, Rupa Banerjee, Saroj Kant Sinha, Siew Chien Ng, Stephen Hanauer, Suhang Verma, Usha Dutta, Vandana Midha, Varun Mehta, Vineet Ahuja, Ajit Sood. Use of thiopurines in inflammatory bowel disease: an updateIntestinal Research 2022; 20(1): 11 doi: 10.5217/ir.2020.00155
14
Julián Panés, Javier P. Gisbert. Eficacia de tofacitinib en el tratamiento de la colitis ulcerosaGastroenterología y Hepatología 2019; 42(6): 403 doi: 10.1016/j.gastrohep.2019.03.002
15
James J. Ashton, R. Mark Beattie. Treatment of Active Crohn’s Disease With an Ordinary Food-Based Diet That Replicates Exclusive Enteral NutritionGastroenterology 2019; 157(4): 1160 doi: 10.1053/j.gastro.2019.01.277
16
Samuel Sassine, Souhila Zekhnine, Marwa Qaddouri, Lisa Djani, Christine Cambron‐Asselin, Mathieu Savoie‐Robichaud, Yi Fan Lin, Kelly Grzywacz, Véronique Groleau, Martha Dirks, Éric Drouin, Ugur Halac, Valérie Marchand, Chloé Girard, Olivier Courbette, Natalie Patey, Dorothée Dal Soglio, Colette Deslandres, Prévost Jantchou. Factors associated with time to clinical remission in pediatric luminal Crohn's disease: A retrospective cohort studyJGH Open 2021; 5(12): 1373 doi: 10.1002/jgh3.12684
17
Lieven Pouillon, Johan Van Stappen, Peter Bossuyt, Silvio Danese, Laurent Peyrin-Biroulet. Should we use anti-tumor necrosis factor agents or vedolizumab as first-line biological therapy in ulcerative colitis?Best Practice & Research Clinical Gastroenterology 2018; : 17 doi: 10.1016/j.bpg.2018.05.006
18
Rotem Sigall Boneh, Johan Van Limbergen, Eytan Wine, Amit Assa, Ron Shaoul, Peri Milman, Shlomi Cohen, Michal Kori, Sarit Peleg, Avi On, Hussein Shamaly, Lee Abramas, Arie Levine. Dietary Therapies Induce Rapid Response and Remission in Pediatric Patients With Active Crohn’s DiseaseClinical Gastroenterology and Hepatology 2021; 19(4): 752 doi: 10.1016/j.cgh.2020.04.006
19
Ignacio Marín-Jiménez, Manuel Barreiro-de Acosta, María Esteve, Luisa Castro-Laria, Santiago García-López, Daniel Ceballos, Ana Echarri, María Dolores Martín-Arranz, David Busquets, Jordina Llaó, Mercè Navarro-Llavat, José María Huguet, Federico Argüelles-Arias, Raquel Vicente, José Miguel Boudet, Gema Díaz, Ana M. Sánchez-Migallón, Francesc Casellas. Rapidity of clinical response to adalimumab and improvement of quality of life in luminal Crohn's disease: RAPIDA studyGastroenterología y Hepatología 2022; 45(3): 165 doi: 10.1016/j.gastrohep.2021.04.010
20
Marco Vincenzo Lenti, Vivien Dolby, Tanya Clark, Veronica Hall, Suzanne Tattersall, Francesca Fairhurst, Catherine Kenneth, Rachael Walker, Karen Kemp, Simon Borg‐Bartolo, Jimmy K. Limdi, Jo Taylor, Tristan Townsend, Sree Subramanian, Daniel Storey, Arash Assadsangabi, Catherine Stansfield, Paul Smith, Debra Byrne, Annalisa De Silvestri, Christian P. Selinger. A propensity score‐matched, real‐world comparison of ustekinumab vs vedolizumab as a second‐line treatment for Crohn’s disease. The Cross Pennine study IIAlimentary Pharmacology & Therapeutics 2022; 55(7): 856 doi: 10.1111/apt.16742
21
Neeraj Narula, Emily C.L. Wong, Parambir S. Dulai, Neil K. Sengupta, John K. Marshall, Jean-Frederic Colombel, Walter Reinisch. Comparative Efficacy and Rapidity of Action for Infliximab vs Ustekinumab in Biologic Naïve Crohn’s DiseaseClinical Gastroenterology and Hepatology 2022; 20(7): 1579 doi: 10.1016/j.cgh.2021.04.006
22
Réme Mountifield. Anti‐tumor necrosis factors (TNFs) are outdated—It's time to move on: Session three summaryJournal of Gastroenterology and Hepatology 2021; 36(S1): 25 doi: 10.1111/jgh.15455
23
Ping Zhu, Jin-fang Sun, Yun-fei Gu, Hong-jin Chen, Min-min Xu, You-ran Li, Bo-lin Yang. Combined therapy with early initiation of infliximab following drainage of perianal fistulising Crohn’s disease: a retrospective cohort studyBMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-021-02078-9
24
Danny Con, Nina Parthasarathy, Maria Bishara, Raphael P Luber, Neetima Joshi, Anna Wan, James A Rickard, Tony Long, Declan J Connoley, Miles P Sparrow, Peter R Gibson, Daniel R van Langenberg, Abhinav Vasudevan. Development of a Simple, Serum Biomarker-based Model Predictive of the Need for Early Biologic Therapy in Crohn’s DiseaseJournal of Crohn's and Colitis 2021; 15(4): 583 doi: 10.1093/ecco-jcc/jjaa194
25
Johan F K F Ilvemark, Tawnya Hansen, Thomas M Goodsall, Jakob B Seidelin, Heba Al- Farhan, Mariangela Allocca, Jakob Begun, Robert V Bryant, Dan Carter, Britt Christensen, Marla C Dubinsky, Krisztina B Gecse, Torsten Kucharzik, Cathy Lu, Christian Maaser, Giovanni Maconi, Kim Nylund, Carolina Palmela, Stephanie R Wilson, Kerri Novak, Rune Wilkens. Defining Transabdominal Intestinal Ultrasound Treatment Response and Remission in Inflammatory Bowel Disease: Systematic Review and Expert Consensus StatementJournal of Crohn's and Colitis 2022; 16(4): 554 doi: 10.1093/ecco-jcc/jjab173
26
Ignacio Marín-Jiménez, Manuel Barreiro-de Acosta, María Esteve, Luisa Castro-Laria, Santiago García-López, Daniel Ceballos, Ana Echarri, María Dolores Martín-Arranz, David Busquets, Jordina Llaó, Mercè Navarro-Llavat, José María Huguet, Federico Argüelles-Arias, Raquel Vicente, José Miguel Boudet, Gema Díaz, Ana M. Sánchez-Migallón, Francesc Casellas. Rapidity of clinical response to adalimumab and improvement of quality of life in luminal Crohn's disease: RAPIDA studyGastroenterología y Hepatología (English Edition) 2022; 45(3): 165 doi: 10.1016/j.gastre.2021.04.007
27
Guillaume Bonnaud, Yoram Bouhnik, Hervé Hagege, Xavier Hebuterne, Benjamin Pariente, Xavier Roblin, Laurent Peyrin-Biroulet. Monitoring of inflammatory bowel disease in 2019: A French consensus for clinical practiceDigestive and Liver Disease 2020; 52(7): 704 doi: 10.1016/j.dld.2020.03.033
28
Isadora Sayuri Macedo da Silva, Maria Paula Carlini Cambi, Daniéla Oliveira Magro, Paulo Gustavo Kotze. Perioperative Nutritional Optimization in Inflammatory Bowel Diseases: When and How?Journal of Coloproctology 2021; 41(03): 295 doi: 10.1055/s-0041-1730369
29
Christopher Ma, Jeffrey K. Lee, Anish R. Mitra, Anouar Teriaky, Daksh Choudhary, Tran M. Nguyen, Niels Vande Casteele, Reena Khanna, Remo Panaccione, Brian G. Feagan, Vipul Jairath. Systematic review with meta-analysis: efficacy and safety of oral Janus kinase inhibitors for inflammatory bowel diseaseAlimentary Pharmacology & Therapeutics 2019; 50(1): 5 doi: 10.1111/apt.15297
30
Beth-Ann Norton, Anne Sullivan, Jennifer Senior, Ninfa Candela, Mary Jason, Katherine Weyant. Vedolizumab for Moderate to Severe Ulcerative Colitis: A Review for Nurse PractitionersThe Journal for Nurse Practitioners 2022; 18(4): 438 doi: 10.1016/j.nurpra.2021.12.001
31
Gregory Gaspard, Samir Hussaini, Dileep Mandali, Ethan Lieberamn. Clinical Approaches to Hospital Medicine2022; : 23 doi: 10.1007/978-3-030-95164-1_2
32
Turki AlAmeel, Eman Al Sulais, Tim Raine. Methotrexate in inflammatory bowel disease: A primer for gastroenterologistsSaudi Journal of Gastroenterology 2022; 0(0): 0 doi: 10.4103/sjg.sjg_496_21
33
Julián Panés, Javier P. Gisbert. Efficacy of tofacitinib treatment in ulcerative colitisGastroenterología y Hepatología (English Edition) 2019; 42(6): 403 doi: 10.1016/j.gastre.2019.03.012
34
Maia Kayal, Shailja Shah. Ulcerative Colitis: Current and Emerging Treatment StrategiesJournal of Clinical Medicine 2019; 9(1): 94 doi: 10.3390/jcm9010094
35
Andrea Cassinotti, Alberto Batticciotto, Marco Parravicini, Maurizio Lombardo, Paolo Radice, Claudio Camillo Cortelezzi, Simone Segato, Federico Zanzi, Antonella Cappelli, Sergio Segato. Evidence-based efficacy of methotrexate in adult Crohn’s disease in different intestinal and extraintestinal indicationsTherapeutic Advances in Gastroenterology 2022; 15: 175628482210858 doi: 10.1177/17562848221085889